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Abstract (200 word limit) 2 2 Aim: To investigate the role of epithelial sodium channels (ENaC) on lung fluid clearance in 3 response to normobaric hypoxia, twenty healthy subjects were exposed to 15 hours of hypoxia 4 (FiO2=12.5%) on two randomized occasions: 1) inhaled amiloride (A) (1.5mg/5ml saline); and 2) 5 inhaled saline placebo (P). Changes in lung fluid were assessed via chest CT for lung tissue 6 volume (TV), and the diffusion capacity of the lung for carbon monoxide (DLCO) and nitric 7 oxide (DLNO) for pulmonary-capillary blood volume (VC). Extravascular lung water (EVLW) 8 was derived as TV-VC and changes in the CT attenuation distribution histograms were reviewed. 10 11 Results: Normobaric hypoxia caused 1) a reduction in EVLW (change from baseline for A vs. P, 12 -8.5±3.8 vs. -7.9±5.2%,p<0.05), 2) an increase in VC (53.6±28.9 vs. 53.9±52.3%,p<0.05) 3) a 13 small increase in DLCO (9.6±29.3 vs. 9.9±23.9%,p>0.05), and 4) CT attenuation distribution 14 became more negative, leftward skewed, and kurtotic (p<0.05). 15 15 Conclusion: Acute normobaric hypoxia caused a reduction in lung fluid that was unaffected by 16 ENaC inhibition via inhaled amiloride. Although possible amiloride-sensitive ENaC may not be 17 necessary to maintain lung fluid balance in response to hypoxia, and it is more probable that 18 normobaric hypoxia promotes lung fluid clearance rather than accumulation for the majority of 19 healthy individuals. The observed reduction in interstitial lung fluid means alveolar fluid 20 clearance may not have been challenged. 22 23 21 Keywords: chest computed tomography (CT), diffusion capacity of the lungs for carbon 22 monoxide and nitric oxide (DLCO/DLNO), epithelial sodium channels (ENaC) 
24
Pulmonary edema results from an imbalance between forces driving fluid into the alveoli, 25 namely Staring's Law of fluid filtration and the integrity of the alveolar-capillary barrier and the 26 biological mechanisms for its removal, primarily active sodium (Na+) transport, which 27 osmotically drives water reabsorption from the alveolar space, and lymphatic drainage. Hypoxic 28 pulmonary vasoconstriction plays a role in the development of high-altitude pulmonary edema 29 (HAPE) (Motley and others 1947; Sartori and others 2004; Swenson 2013) . The increase in 30 capillary hydrostatic pressure results in an increase in net filtration of fluid from the capillary to 31 the interstitial space. Fluid that has been filtered, but not reabsorbed from the interstitial space, is 32 then removed by the pulmonary lymphatics. Stimulation of increased lung lymph flow can occur 33 in response to beta-2 adrenergic receptor stimulation mediated by increases in catecholamines, 34 and increases in ventilation. These events will deform the tissue lympathic vessels attach to, and 35 thereby facilitate pumping and production of lymph (Ikomi and others 1991; Mahe and others 36 1991; Pearse and others 2005; Zawieja 2009 ). Previous work by our group demonstrated that 37 exposure to normobaric hypoxia increases ventilation and catecholamines and reduces lung fluid 38 (Snyder and others 2006; Snyder and others 2008) . The close proximity of the capillaries to the 39 alveoli allows for optimal gas exchange, but this closeness also subjects the alveoli to potential 40 fluid infiltration in conditions such as higher pulmonary artery pressure and increased pulmonary 41 vascular resistance which can result in fluid accumulation in the interstitial space and if not 42 cleared cause fluid to build up in the alveoli. Because of the inverse and exponential relationship 43 between rate of diffusion and membrane thickness, increases in airway surface liquid (ASL) that 44 are not quickly reabsorbed will increase the distance across the alveolar-capillary membrane and 45 greatly impact rate of diffusion and alveolar-capillary membrane conductance (DM). Lungs must 46 be kept moist, but not wet for effective and efficient gas diffusion. The principal determinant of 47 ASL depth is the mass of salt on the airway surface (Boucher 1999) .
48
Active transport of Na+ from the airspace through epithelial sodium channels (ENaC) and 49 then across the basolateral membrane by Na+/K+ ATPase is believed to be the primary 50 determinant of alveolar fluid clearance by creating an osmotic gradient, with ENaC-mediated 51 Na+ absorption being the rate limiting step (Matthay and others 2002; Matthay and others 1996) . The randomization and preparation for the administration of nebulized amiloride (1.5mg 150 in 5mL saline) and nebulized saline placebo (5mL saline) was performed by the Mayo Clinic
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CRU pharmacy ensuring that the study investigators, technicians, nursing staff and subjects were 152 blinded. Amiloride and saline were nebulized using standard apparatus (ReliaMed) connected to 150 a room air supply flowing at 8L/min. Each treatment was administered at three time points 151 during exposure to hypoxia: 1) upon entering the tent at 16:00; 2) 21:00; and 3) 4:00 the 152 following morning. The investigators were unblinded after all subjects had completed the study. 166 instructed the subject to take a maximal inhalation and hold their breath at the total lung 167 capacity. At this time the study team signaled the radiology technician to complete the scan, and 168 once through the scanner the subject was told they could relax and return to normal breathing.
169 Although a gated spirometer was not used to control lung volumes, the difference between 170 baseline and post exposure to hypoxia CT derived air volumes was on average less than 5%.
171
The CT images were then analyzed using custom image analysis software (Apollo, VIDA subject's CT scan. The software segments the image to separate lung tissue from surrounding structures. In each picture element, the lung density was assumed to be a linear combination of air which has a Hounsfield units = -1000, and lung tissue which has the density of water, HU= 0. As such, an element at -600 HU represents 40% tissue, and -300 HU would represent 70% tissue. A histogram analysis of the picture elements within the lung tissue area was performed to obtain a mean lung density in HU and a tissue volume by summation of all the elements in the lung fields.
The density and tissue volumes (TV) can also be determined for individual lobes of the lung.
Two different methods were used to assess lung water from the CT. First, an estimation of extravascular lung water (EVLW). Since the tissue volume measured from the CT scan consists of lung tissue, blood and water, we subtracted the pulmonary capillary blood volume obtained from the DLCO and DLNO measures to remove the blood component (EVLW = TV -VC). If we then assume tissue volume remains relatively constant between the pre and post scans, any change in the EVLW describes changes in lung fluid. Second, differences in EVLW between study conditions were estimated using a histogram analysis approach. Lung interstitial tissue was segmented from surrounding tissue, large airways, and blood vessels using segmentation algorithms built in MATLAB (Mathworks, Inc., Natick, MA). CT attenuation distributions were generated from the segmented images. Mean, skew, kurtosis, and full-width half-max (FWHM)
were calculated from these distributions (Chase and others 2016) . When the attenuation becomes less attenuated or more negative, more skewed to the left and/or more kurtotic this collectively suggest less fluid as the attenuation distribution is becoming less dense, and shifting away from 
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The rate of disappearance of acetylene from the exhaled gas mixture during rebreathing is 220 used to assess pulmonary blood flow. Since acetylene does not bind to hemoglobin, the rate of 221 disappearance of acetylene is limited primarily by the rate at which a new volume of blood is 222 transported through the lungs. Because all the blood in the pulmonary circulation per minute is 223 equal to the volume of blood in the systemic circulation per minute, the measure of the disappearance of acetylene provides a reliable measure of cardiac output and has previously been 224 validated in our laboratory using direct Fick during exercise (Johnson and others 2000; Liu and 225 others 1997).
226
The diffusing capacity of the lungs for carbon monoxide is based on the contribution of 227 both the membrane conductance and the hemoglobin binding and described by the equation
228
developed by Roughton & Forester (Tamhane and others 2001) .
The rate of disappearance of the gases with each breath is calculated from the slope of the 230 exponential disappearance for each gas with respect to helium using custom software (Snyder and Pulmonary Arterial Pressure Pulmonary arterial pressure was calculated from the tricuspid regurgitation (TR) velocity as described previously (Yock and Popp 1984) using the equation AP=A4V , where P is the pressure and V (m/s) is the tricuspid regurgitant velocity. The same sonographer performed the echocardiographic measures at baseline and after the fifteen hours of hypoxic exposure being performed before the subject was removed from the tent. There were three sonographers who performed these measurements on the subjects, all of them using the following methods for their assessment. Color Doppler was used to locate the tricuspid regurgitation jet. Data reported are from sixteen out of twenty subjects for whom a jet could be visualized and successfully measured. The maximal velocity was determined by careful application of the continuous wave sampler within and parallel to the regurgitation jet.
Statistical Analysis
The SPSS statistical software package (v.22; SPSS, Inc., Chicago, IL) was used for all statistical analyses. Two-factor repeated measure ANOVA was used to evaluate the main effects of normobaric hypoxia, drug (amiloride vs. placebo) and their interaction on the measures of lung fluid and systemic response to the conditions. Paired samples t-tests were performed between percent change from baseline to post exposure to hypoxia metrics (LLS, urine input/output) for the two treatments, with an alpha level of 0.05 used to determine statistical significance. All values presented are mean ±SD unless otherwise stated. (Figure 2 ). By contrast, hypoxic 295 exposure caused an increase in pulmonary capillary blood volume (VC) (hypoxia effect p<0.01);
296 the magnitude of increase in Vc was not different in amilioride vs. placebo (54±29% vs.
297 54±52%, p= 0.52) (Figure 2 ). There was a reduction in CT derived tissue volume in response to 298 hypoxic exposure (hypoxia effect p=<0.01) that was similar between amiloride and placebo 299 conditions (-49.3±25.7 vs. -46.1±31.2 mL, p=0.69) (Figure 3 ). This decrease in tissue volume 300 was not uniform across the lungs, with a minimal reduction (~2 ml) in the mid-right lobe, a 10 to 301 13 ml reduction in the left lobes and upper right lobe, and a trend for a larger decrease, especially 302 with amiloride, in the lower right lobe (~16ml) (Figure 4 ). There was a similar and significant 303 decrease in EVLW from before to after hypoxic exposure (hypoxia effect p<0.01) with amiloride 304 and placebo (-8.5±3.8% vs. -7.9±5.2%, p=0.53) (Figure 3 ). CT attenuation distributions showed 305 the same trend for EVLW. Distribution average was shifted more negative, more leftward 306 skewed, and more kurtotic after hypoxic exposure in both groups suggesting clearance of fluid 307 from the lungs due to the shift towards less attenuation (hypoxia effect p<0.05, Table 3 ). There 308 was no difference in these changes between amiloride and placebo conditions (p>0.05).
309 Additionally, there was a decrease in plasma volume with hypoxic exposure (hypoxia effect p<0.01) for both conditions amiloride vs. placebo (-9.2±9.7 vs. -11.0+11.0 p= 0.52) suggesting that the decrease in EVLW was not just a shift of fluid from the interstitial to vascular space.
Although there was a decrease in interstitial lung fluid with hypoxia and no effect of amiloride in the gross measures of changes in EVLW or on diffusion capacity or alveolarcapillary membrane conductance, a measure of alveolar fluid, there were still signs of ENaC inhibition. First, utilizing EBC Na+ to assess changes in alveolar lung fluid suggested a trend for a decrease with placebo, but an increase with amiloride as was expected with amiloride inhibiting ENaC mediated-sodium absorption at the level of the alveolar epithelium. Second, in the fourteen subjects fluid input and output was recorded and although the pairwise comparison was not significant (p =0.44, Table 4 ), review of the individual responses under each condition shows the variability, and demonstrates that in eight subjects fluid loss was greater with amiloride compared to only four participants where fluid loss that was greater with the placebo than with amiloride, and two participants who showed no real difference between conditions ( Figure 5 ).
Systemic Responses to Normobaric Hypoxia Exposure
The systemic responses to the normobaric hypoxia exposure are presented in Table 4 .
There was no change in cardiac output with hypoxic exposure (hypoxia effect p>0.05) and no difference between conditions amiloride vs. placebo (p=0.99), and the increase in systolic pulmonary arterial pressure was small (hypoxia effect p=0.02) and not different between amiloride vs. placebo visits (p=0.41). Hypoxic exposure caused a significant increase in HR with normobaric hypoxia (hypoxia effect p<0.01) that was not different between conditions (p=0.23).
There was a trend for a reduction in norepinephrine concentration from pre-to post-hypoxia in However, in this current study alveolar fluid clearance rate appeared to be unchanged as there was no change in DLCO or DM with exposure to hypoxia. One possible explanation for this is that although in both studies subjects were kept in hypoxia until and between all measurements, in the current study the DLCO gas mixture used for post hypoxia measurements was the same as baseline where the oxygen concentration was 35%, where as in the previous study a special hypoxic DLCO gas mixture was used where the oxygen concentration was 18%. Since the change previously observed was not drastic (+10%), the potential of reoxygenation over the 10 breaths of the non-hypoxic DLCO gas may have limited our ability to measure a change with hypoxia in the current study. The results of these studies seem to highlight that the observed fluid reduction is predominantly interstitial fluid removal. As such, lymphatic drainage is potentially of greater importance and the primary mediator of the observed reduction in lung fluid. Previous work in sheep and dogs has shown that lymph flow increases 10-40% with hypoxia (Levine and others 1988; Martin and others 1986 ) and the increases in ventilation experienced with hypoxia also facilitate pumping and production of lymph (Ikomi and others 1991; Mahe and others 1991; Pearse and others 2005; Zawieja 2009 ). Additionally, in our previous study we observed an increase in exhaled nitric oxide with normobaric hypoxia exposure (Snyder and others 2006; Van Iterson and others 2017) . In the thoracic lymphatic duct of rat, initiation of spontaneous contraction of the phasically non-active segments results in nitric oxide mediated relaxation of these segments. This reduction in lymphatic vessel tone improves diastolic filling of the vessels and although contraction rate is reduced, lymphatic contractions are stronger making overall lymphatic pumping more efficient (Gashev 2008; Gasheva and others 2006) . As such, we 380 hypothesize that the reduction in interstitial lung fluid observed in this study and in previous 381 work in response to normobaric hypoxia is primarily driven by increases in lymphatic fluid 382 clearance mediated by 1) increases in minute ventilation likely elevated due to increases in tidal 383 volume, since we did not observe an increase in respiratory rate and 2) increases in NO 384 mediating relaxation of the lymphatics such that they can more efficiently clear any excess 385 interstitial fluid that is not reabsorbed.
386 Is impairment of ENaC function really insufficient to cause pulmonary edema in response to 387 hypoxic exposure?
388 First, at least two types of Na + channels have been identified to exist in the alveolar epithelium 389 each with very different regulation, and quite often opposite response to the same stimuli (Eaton 390 and others 2004; Trac and others 2017) . ENaC is composed of three homologous subunits: a-391 ENaC, P-ENaC and y-ENaC. It is the ratio and combination of these subunits that can produce 392 channels with varying conductances and regulatory properties. When a channel is composed of 393 all three subunits then the channel has high Na + selectivity and falls into the highly selective 394 channel (HSC) type. In contrast, nonselective cation channels (NSC), or amiloride insensitive 395 channels, are composed of at least one a-ENaC subunit and at least one acid-sensing ion channel 396 1(ASIC1a) and the channel has low Na+ selectivity or no selectivity, making it likely to secrete 397 K+ rather than absorb Na+ (Trac and others 2017) . Hypoxia can cause a shift from HSC to NSC as 398 hypoxia reduce HSC or ENaC channelsm, but increase NSC expression (Jain and others 2001; 399 Trac and others 2017) , and reduces sodium transport across the airway epithelium (Tomlinson 400 and others 1999b) . In rats it was demonstrated that amiloride caused a greater drop in 401 transepithelial Na+ flux, measured by nasal potential difference (NPD), than hypoxia alone. With 402 hypoxia and amiloride there was no additional reduction in Na + current, suggesting that the insensitive Na+ current by ~30%, with no change in the amiloride sensitive Na+ current, and this was only HAPE-prone subjects (Sartori and others 2004) . In contrast, Mairbaurl et al found that total NPD became more positive due to increased chloride secretion, occurring in response to nasal dryness, and an observed increase in the amiloride insensitive Na+ current in both control.
The amiloride-dependent Na+ reabsorption decreased in control subjects, while remained unchanged in HAPE-prone individuals (Mairbaurl and others 2003) . Additionally, previous cell and tissue work has found that the 40-50% of the Na+ and airway fluid clearance occurs through Future work should follow up with nasal potential difference measurements to provide an additional measure of changes in ion flux in the airway epithelium in response to hypoxia with and without amiloride. We also have signs that the nebulized amiloride was being absorbed across the epithelia and acting on the kidneys to cause diuresis as there is a trend for a higher net urine output with amiloride. This observed diuretic effect aligns with earlier pharmacokinetic work showing that after aerosol delivery, amiloride plasma concentration peaks by 30 minutes and 50% of amiloride has been excreted by four to six hours post administration (Noone and others 1997) .
Although this study did not show that ENaC was necessary for preventing lung fluid accumulation, it does not discount the role of ENaC in regulating alveolar lung fluid clearance.
ENaC has been demonstrated to be necessary for fetal alveolar lung fluid clearance, where knock out of alpha ENaC caused a failure to thrive in mice (Mall and others 2004) , but this study and the work of others suggests that the role of amiloride-sensitive ENaC is not primary or solely responsible for maintaining lung fluid homeostasis in response to normobaric or hypobaric hypoxia. ENaC's role in lung fluid balance is alveolar fluid clearance and in response to normobaric hypoxia we do not observe that this role is challenged, such that it is not needed or necessary to maintain lung fluid balance. The current study and previous work have demonstrated that exposure to normobaric hypoxia promotes lung fluid clearance rather than accumulation for the majority of individuals (Snyder and others 2006; Snyder and others 2008) 472 meaning that even with amiloride inhibition of ENaC, complete or partial, alveolar fluid 473 clearance is not really challenged as there is not a buildup of interstitial fluid that can potentially 474 move into the alveoli. As such, we conclude that ENaC may not be necessary to maintain gross 475 lung fluid homeostasis in response to normobaric hypoxia in healthy, non-HAPE susceptible 476 individuals, but instead its role in more fine tuning and alveolar fluid balance and in this 477 exposure there was no alveolar edema to prevent. 486 same between this study and our previous study, the degree of hypoxemia experienced by the 487 subjects in the current study was slightly less, with an average SpO2 around 85% overnight and 488 less than 20 minutes at a SpO2 less than 80% in the current study compared to an average of 82% 489 overnight in the previous study. In the current study, participants demonstrated an increase in 490 HR of less than 15 bpm, a small increase in PAP, no change in respiratory rate and no rise in 491 catecholamines whereas in our previous work we saw an average 14 bpm increase in HR, a 492 doubling of PAP, and an increase in both EPI and NE with 17 hours of normobaric hypoxia 493 exposure (Snyder and others 2006 (Bloom and others 1977) . With an average peripheral desaturation greater than 80%, it is unlikely that there was a severe decline in arterial O2 (80% SpO2 = PaO2 ~50mmHg), and as such not a strong enough stimulus for EPI release from the medulla. Alveolar fluid clearance, where ENaCs plays a role, would only be challenged when net fluid balance is disrupted such that there is more fluid moving from the pulmonary vessels to the interstitial space than can be removed by the lymphatic vessels; as then this excess fluid has the potential to shift into the alveolar space. With no change in catecholamines and no increase in pulmonary arterial pressure and a reduction in lung fluid in the current study, the hypoxia exposure likely did not challenge alveolar fluid clearance such that amiloride mediated impairment in alveolar transepithelial Na + transport would compromise lung fluid clearance.
Additionally, further work is needed to evaluate the role of ENaC in lung fluid, both alveolar and interstitial, to determine if these observations also hold true in HAPE-susceptible individuals.
Conclusion
Acute normobaric hypoxia caused a reduction in lung fluid volume that was unaffected by 15.8+15.3 18.3+16.1 SpO2= peripheral oxygen saturation; HR= heart rate; EPI= epinephrine; NE= norepinephrine; FVC=forced vital capacity; FEV1=forced expiratory volume after one second of FVC; FEF25-75= forced expiratory flow at 25-75% of FVC; FEF75= forced expiratory flow at 75 % of FVC; PEF= peak expiratory flow; EBC Na+= exhaled breathe condensate Na+; Modified Lake Louise Score is out of 30 and averaged over their tent exposure; Percent of time SpO2<80%= percent of time in tent that nonin wrist stats dropped below 80%. Data are presented as mean±SD.* p<0.05 vs. baseline The average SpO2 noted by the CRU nurse every two hours in subjects during their amiloride visit (black squares) and placebo visit (open black circles). Black arrows represent the time when amiloride/placebo was nebulized. The change in SpO2 from baseline every two hours is presented for amiloride (grey squares) and placebo (open grey circles). Standard deviation is not presented on figure to keep figure clear. Amiloride SD: mean ±4.4; range (1.2-5.6). Placebo SD: mean ±4.4; range (3.2-5.9). Amiloride delta SD: mean ±5.1; range (3.9-6.0). Placebo delta SD: mean ±6.3; range (4.9-8.1).
